Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioage LabsHAM:Y7G -7.55%20 Days Inventory is 0.00 as of Jun. 2026. GuruFocus rates HAM:Y7G with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Bioage Labs ranks worse than 108695.54% on this metric.
The historical rank and industry rank for Bioage Labs's Days Inventory or its related term are showing as below:
HAM:Y7G's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 165.11 * Ranked among companies with meaningful Days Inventory only.
Bioage Labs's Days Inventory
stayed the same
from Jun. 2025 (0.00) to Jun. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioage Labs's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.00.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bioage Labs's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioage Labs's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bioage Labs Days Inventory Related Terms
Bioage Labs Days Inventory Historical Data
* Premium members only.
The historical data trend for Bioage Labs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:Y7G vs PCRX, ALVO, AMPH: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bioage Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioage Labs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bioage Labs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bioage Labs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioage Labs (HAM:Y7G) has a Days Inventory of 0.00 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bioage Labs and its competitors. According to the industry distribution chart, Bioage Labs ranks #999999 out of 920 companies in the Drug Manufacturers industry.
Is Bioage Labs' Days Inventory too high?
Bioage Labs' current Days Inventory is 0.00. Based on the distribution chart, Bioage Labs ranks #999999 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bioage Labs has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Bioage Labs' Days Inventory compare to PCRX and ALVO?
According to the Drug Manufacturers industry distribution chart, Bioage Labs ranks #999999 out of 920 companies for Days Inventory. This places Bioage Labs in the lower half of its industry. The industry median Days Inventory is 165.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.11, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bioage Labs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioage Labs's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioage Labs stock overvalued right now?
Bioage Labs (HAM:Y7G) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Bioage Labs' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bioage Labs (HAM:Y7G), the current Days Inventory is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
20GF Score
Get the complete analysis for HAM:Y7G
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:Y7G has been successfully added to your 
